1. MicroRNAs and Nonalcoholic Steatohepatitis: A Review
   Asahiro Morishita et al, 2023, International Journal of Molecular Sciences CrossRef
2. A review on the importance of miRNA-135 in human diseases
   Sepideh Kadkhoda et al, 2022, Frontiers in Genetics CrossRef
3. Role and therapeutic perspectives of extracellular vesicles derived from liver and adipose tissue in metabolic dysfunction-associated steatotic liver disease
   Wandi Li et al, 2024, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
4. Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease
   Lauren A. Newman et al, 2022, Biomedicines CrossRef
5. Role of extracellular vesicles in nonalcoholic fatty liver disease
   Wei Jiang et al, 2023, Frontiers in Endocrinology CrossRef
6. Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
   Yan-Lin Wu et al, 2023, Signal Transduction and Targeted Therapy CrossRef
7. MiR-337-3p improves metabolic-associated fatty liver disease through regulation of glycolipid metabolism
   Xiaoding Xu et al, 2023, iScience CrossRef
8. The Role of Extracellular Vesicles in Metabolic Diseases
   Carlos González-Blanco et al, 2024, Biomedicines CrossRef
9. Micro RNAs as Emerging Therapeutic Targets in Liver Diseases
   Subheet Kumar Jain et al, 2022, Current Protein & Peptide Science CrossRef
10. Evaluation of the diagnostic role of circulating miR-16, miR-10b, and miR-21 expression in patients with nonalcoholic fatty liver disease
    Fatemeh Amani et al, 2024, Gene Reports CrossRef
11. Role of non-coding RNAs on liver metabolism and NAFLD pathogenesis
    Gene Qian et al, 2022, Human Molecular Genetics CrossRef
12. Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD
    Stefania Di Mauro et al, 2021, International Journal of Molecular Sciences CrossRef
13. Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
    Bo Zhu et al, 2021, Frontiers in Cardiovascular Medicine CrossRef
14. Two sides of the same coin: Non-alcoholic fatty liver disease and atherosclerosis
    Bo Zhu et al, 2024, Vascular Pharmacology CrossRef
15. The Emerging Role of Extracellular Vesicles and Autophagy Machinery in NASH—Future Horizons in NASH Management
    Eleni-Myrto Trifylli et al, 2022, International Journal of Molecular Sciences CrossRef
16. Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases
    Arianna Ferro et al, 2024, Biomolecules CrossRef
17. Research advances and challenges in tissue-derived extracellular vesicles
    Zhengke Zhi et al, 2022, Frontiers in Molecular Biosciences CrossRef
18. Effect of LncPVT1/miR-20a-5p on Lipid Metabolism and Insulin Resistance in NAFLD
    Han Zhang et al, 2021, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy CrossRef
19. Protective effects of baicalin magnesium on non-alcoholic steatohepatitis rats are based on inhibiting NLRP3/Caspase-1/IL-1β signaling pathway
    Xiulu Guan et al, 2023, BMC Complementary Medicine and Therapies CrossRef